TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26976420

Group type: EXPERIMENTAL
Intervention: High fluid intake along with antimyeloma therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-cutoff hemodialysis membranes in combination with antimyeloma therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib-based regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose therapy with autologous stem cell transplantation (with melphalan 100 mg/m(2) to 140 mg/m(2))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carfilzomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ixazomib in combination with lenalidomide and dexamethasone
Number of subjects: 0
Study: 25010566

Group type: EXPERIMENTAL
Intervention: Handling in lateral decubitus
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Handling in ventral decubitus
Number of subjects: 31
Study: 22921891

Group type: EXPERIMENTAL
Intervention: E3 allele presence
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: E4 allele presence
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: E2 allele presence
Number of subjects: 843
Study: 20605504

Group type: EXPERIMENTAL
Intervention: Screening for chest symptoms related to TB and collection of sputum samples; methods: Ziehl‐Neelsen smear microscopy and solid media culture.
Number of subjects: 11468
Study: 17585311

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15704776

Group type: EXPERIMENTAL
Intervention: IJ-CVLP training
Number of subjects: 47
Study: 14533654

Group type: EXPERIMENTAL
Intervention: Oral ingestion of biogenic amines (specific types not detailed)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tyramine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenylethylamine in chocolate
Number of subjects: 10
Study: 10608589

Group type: EXPERIMENTAL
Intervention: Acipimox (500 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7851578

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA; Lupron) 0.1 mg SC daily for 3 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Danazol (Danocrine) 800 mg orally daily for 3 months
Number of subjects: 40
Study: 1659236

Group type: EXPERIMENTAL
Intervention: Interim methadone maintenance clinic
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 301
Study: 6108895

Group type: EXPERIMENTAL
Intervention: 150 mg tiotidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 300 mg tiotidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 300 mg cimetidine
Number of subjects: 0
Study: 31950152

Group type: EXPERIMENTAL
Intervention: Alcohol tolerance assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel medications co-administered with alcohol
Number of subjects: 0
Study: 30706865

Group type: EXPERIMENTAL
Intervention: Virtual microscopy (VM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Light microscopy (LM)
Number of subjects: 64
Study: 28646807

Group type: EXPERIMENTAL
Intervention: Kaltenborn‐Evjenth orthopedic manual therapy (KEOMT) combined with cryotherapy (KEOMT‐C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Kaltenborn‐Evjenth orthopedic manual therapy (KEOMT) combined with Kinesio taping (KEOMT‐K)
Number of subjects: 40
Study: 25644582

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 14
Study: 24317968

Group type: EXPERIMENTAL
Intervention: Supervised resistance + impact training
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 67
Study: 22402257

Group type: EXPERIMENTAL
Intervention: EE 20 mcg/drsp 3 mg in a 21/7-day regimen
Number of subjects: 53
Study: 19671292

Group type: EXPERIMENTAL
Intervention: Multimodal group (Group M) with intravenous fentanyl and atracurium, inhalation of nitrous oxide/oxygen (50%:50%) and sevoflurane (5%)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Multimodal group (Group M)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (Group C) with inhalation of nitrous oxide/oxygen (50%:50%) and sevoflurane (5%)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 54
Study: 17296408

Group type: EXPERIMENTAL
Intervention: Spanner
Number of subjects: 186
Study: 17722318

Group type: EXPERIMENTAL
Intervention: 50 microg oral misoprostol
Number of subjects: 146

Group type: COMPARATOR
Intervention: 25 microg vaginal misoprostol
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 146
Study: 12374912

Group type: EXPERIMENTAL
Intervention: Bioactive glass grafting
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nongrafted sites
Number of subjects: 14
Study: 10195521

Group type: EXPERIMENTAL
Intervention: Capnographic determination of ETCO2
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Auscultation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Esophageal detection method (EDM) using a self‐inflating bulb
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Transillumination method using a lighted stylet (Trachlight)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison of all four methods
Number of subjects: 38
Study: 7591353

Group type: EXPERIMENTAL
Intervention: Soap opera videotape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rap videotape
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined videotapes (soap opera and rap)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discussion group control
Number of subjects: 0
Study: 2274744

Group type: COMPARATOR
Intervention: Clofibrate (2.0 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1.2 g/day)
Number of subjects: 0
Study: 7030652

Group type: EXPERIMENTAL
Intervention: Flunisolide aerosol 0.5 mg (two inhalations) twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 28763311

Group type: EXPERIMENTAL
Intervention: PEWS Model 1
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: PEWS Model 2
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Individual PEWS measurements
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Aggregated PEWS scores
Number of subjects: 108
Study: 28532871

Group type: EXPERIMENTAL
Intervention: Postural insoles
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Postural insoles combined with conventional physical therapy
Number of subjects: 24
Study: 25819701

Group type: EXPERIMENTAL
Intervention: Behavioral activation delivered by psychological therapists
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy based self-help introduced by CDAT workers
Number of subjects: 50
Study: 23665671

Group type: COMPARATOR
Intervention: 3 ml normal saline with 1:200,000 epinephrine per tonsil (Group 1)
Number of subjects: 172

Group type: COMPARATOR
Intervention: 3 ml 1% lidocaine with 1:200,000 epinephrine per tonsil (Group 2)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 8 ml normal saline with 1:200,000 epinephrine per tonsil (Group 3)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 8 ml lidocaine with 1:200,000 epinephrine per tonsil (Group 4)
Number of subjects: 172
Study: 21110406

Group type: EXPERIMENTAL
Intervention: Psychoanalytic psychotherapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural psychotherapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Narrative Processes Coding System
Number of subjects: 16
Study: 19484917

Group type: EXPERIMENTAL
Intervention: 9.5 mg/24 h rivastigmine patch
Number of subjects: 1195

Group type: EXPERIMENTAL
Intervention: 17.4 mg/24 h rivastigmine patch
Number of subjects: 1195

Group type: COMPARATOR
Intervention: rivastigmine capsule (3 to 6 mg twice-daily)
Number of subjects: 1195
Study: 17784901

Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancement
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Self-help booklet
Number of subjects: 215

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 215
Study: 15549661

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761 (240 mg/d for 3 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (for 3 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761
Number of subjects: 27
Study: 10617956

Group type: EXPERIMENTAL
Intervention: 5:1 LA:ALA formula
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 10:1 LA:ALA formula
Number of subjects: 73

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both formula-fed groups
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: All formula-fed and breast-fed infants
Number of subjects: 73
Study: 9075261

Group type: EXPERIMENTAL
Intervention: Gradual substitution of zopiclone for the initial BZD (Group A)
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Abrupt substitution of zopiclone for the initial BZD (Group B)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Initial BZD (Group C)
Number of subjects: 1002
Study: 1632998

Group type: EXPERIMENTAL
Intervention: In-chart checklist prompt for increasing screening, counseling, and referral for 11 risk behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-chart checklist prompt for patients receiving gynecologic care and birth control
Number of subjects: 0
Study: 6377997

Group type: EXPERIMENTAL
Intervention: Daily streptomycin, isoniazid, rifampin, and pyrazinamide for 2 months
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Daily streptomycin, isoniazid, rifampin, and pyrazinamide for 3 months
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Standard 12‐month control regimen
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Daily streptomycin, isoniazid, rifampin, and pyrazinamide for 12 months
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Selective chemotherapy (antituberculosis chemotherapy not started until disease confirmed active)
Number of subjects: 1019
Study: 30325658

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GH antagonist treatment
Number of subjects: 0
Study: 28440680

Group type: EXPERIMENTAL
Intervention: baricitinib 4mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: baricitinib 8mg
Number of subjects: 145

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: baricitinib 1mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: baricitinib 2mg
Number of subjects: 145
Study: 26232355

Group type: EXPERIMENTAL
Intervention: Any CAM use
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Relaxation techniques
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Dietary change
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Perceived helpfulness of CAM
Number of subjects: 401
Study: 26984931

Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter
Number of subjects: 0
Study: 22076877

Group type: EXPERIMENTAL
Intervention: Femoral catheterization
Number of subjects: 736

Group type: COMPARATOR
Intervention: Jugular catheterization
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Dialysis sessions through femoral catheters
Number of subjects: 736

Group type: COMPARATOR
Intervention: Dialysis sessions through jugular catheters
Number of subjects: 736
Study: 20662423

Group type: EXPERIMENTAL
Intervention: Safety enhancement program
Number of subjects: 185

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 185
Study: 18713891

Group type: EXPERIMENTAL
Intervention: 1% lidocaine (Group II, n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2% lidocaine (Group III, n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.5% bupivacaine (Group I, n = 30, control)
Number of subjects: 90
Study: 15654716

Group type: EXPERIMENTAL
Intervention: LED photomodulation using a full panel 590 nm non‐thermal full face LED array delivering 0.1 J/cm(2)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LED photomodulation
Number of subjects: 90
Study: 12568433

Group type: EXPERIMENTAL
Intervention: Educational program (15-week, 45-hour) on caring for terminally ill persons
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 115
Study: 10655953

Group type: EXPERIMENTAL
Intervention: Inulin (10 g daily)
Number of subjects: 54
Study: 8762415

Group type: EXPERIMENTAL
Intervention: PD + Traditional Chinese Medicine (TCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PD + TCM
Number of subjects: 0
Study: 1987105

Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.5% ophthalmic solution, 1 drop twice daily for 14 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 418431

Group type: EXPERIMENTAL
Intervention: Pimozide tablets
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fluphenazine decanoate injections
Number of subjects: 41
Study: 31831042

Group type: EXPERIMENTAL
Intervention: Preoperative concurrent chemoradiotherapy (n=104)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy alone (n=118)
Number of subjects: 222
Study: 28618097

Group type: EXPERIMENTAL
Intervention: Navigated technique
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 29
Study: 26142578

Group type: EXPERIMENTAL
Intervention: Genomic classifier (GC) test results
Number of subjects: 11

Group type: COMPARATOR
Intervention: Clinical information alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Genomic classifier (GC) test results indicating high metastatic risk
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Genomic classifier (GC) test results indicating low metastatic risk
Number of subjects: 11
Study: 23640204

Group type: EXPERIMENTAL
Intervention: 28‐mm bearing couple
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 36‐mm bearing couple
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ≥ 42‐mm bearing couple
Number of subjects: 60
Study: 21860143

Group type: EXPERIMENTAL
Intervention: Facet joints infiltration (FJI) with depot methylprednisolone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Physiotherapy with McKenzie regimen
Number of subjects: 18
Study: 19222614

Group type: EXPERIMENTAL
Intervention: Dopamine agonist (DA)
Number of subjects: 4380

Group type: COMPARATOR
Intervention: Levodopa therapy alone
Number of subjects: 4380
Study: 18021950

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Temporal pulse amplitude (TPA) biofeedback training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 64
Study: 17406754

Group type: COMPARATOR
Intervention: IFN 3 MU thrice weekly + ribavirin 1.0‐1.2 g daily for 48 weeks (IFN TIW)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: IFN 3 MU daily + ribavirin 1.0‐1.2 g daily for 12 weeks followed by IFN 3 MU thrice weekly + ribavirin 1.0‐1.2 g daily for 48 weeks (IFN QD)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Overall (intention to treat analysis)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Among subjects with HCV genotype‐1
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Among patients with HCV genotype 2 or 3
Number of subjects: 93
Study: 12793140

Group type: EXPERIMENTAL
Intervention: Captopril (capoten) 25‐75 mg/day for 4 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Benazepril (lotensin) 5‐30 mg/day for 24 weeks
Number of subjects: 54
Study: 9988412

Group type: EXPERIMENTAL
Intervention: Human endometrial stromal cells (group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (group A) - embryos cultured alone
Number of subjects: 0
Study: 7778148

Group type: EXPERIMENTAL
Intervention: Paracetamol given 2 h after quinine (n = 7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Paracetamol given 2 h before quinine (n = 7)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Quinine alone (n = 7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Temperature reduction of 1 degree C
Number of subjects: 21
Study: 2212378

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of Fluosol-DA 20%
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 10
Study: 506975

Group type: EXPERIMENTAL
Intervention: Zinc-fortified cereal (providing 25% US Recommended Dietary Allowance per 1 ounce serving)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-zinc-fortified cereals
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Zinc-fortified cereal
Number of subjects: 96
Study: 31927748

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone (4.5 g cumulative dose during 12 weekly infusions)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 15
Study: 30475213

Group type: EXPERIMENTAL
Intervention: Unmatched Count Technique (UCT)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Randomized Response Technique (RRT)
Number of subjects: 708
Study: 27858075

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser combined with total glucosides of paeony (TGP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total glucosides of paeony (TGP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser combined with TGP
Number of subjects: 60
Study: 24234676

Group type: EXPERIMENTAL
Intervention: Hands-on participation group (manual guidance and tactile prompting)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Observation group (hearing words and watching task)
Number of subjects: 34
Study: 22430681

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasonography (CEUS)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Triple-phase computed tomography angiography (CTA)
Number of subjects: 88
Study: 20926264

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 9809

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 9809

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 9809
Study: 18674978

Group type: EXPERIMENTAL
Intervention: Individualized pressure ulcer education and monthly structured telephone follow-up (n=20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Monthly mail or telephone follow-up without educational content (n=11)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Quarterly mail or telephone follow-up without educational content (n=10)
Number of subjects: 41
Study: 16197666

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11979058

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10403866

Group type: EXPERIMENTAL
Intervention: 1.2 ml 0.5% bupivacaine (6 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3.4 ml 0.18% hypobaric bupivacaine (6.1 mg)
Number of subjects: 60
Study: 8534058

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol prep/iodophor‐impregnated adhesive drape method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iodophor scrub and paint prep/plain adhesive drape method
Number of subjects: 0
Study: 2333740

Group type: EXPERIMENTAL
Intervention: Follow-up formula with 1.5 g protein/dl (2.0 g/kg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up formula with 2.2 g protein/dl (3.0 g/kg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up formula with 2.9 g protein/dl (3.7 g/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formula only (15 g/dl)
Number of subjects: 0
Study: 6999291

Group type: EXPERIMENTAL
Intervention: Probucol (1000 mg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31327051

Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity exercise with person-centered guidance
Number of subjects: 74

Group type: COMPARATOR
Intervention: Home-based exercise of light intensity (control)
Number of subjects: 74
Study: 29658258

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) fumigation plus oral Levofloxacin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Oral Levofloxacin only
Number of subjects: 72
Study: 26480551

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation at Renying (ST 9) combined with stellate ganglion block (SGB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple SGB
Number of subjects: 60
Study: 23642941

Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 21288210

Group type: EXPERIMENTAL
Intervention: Paracetamol + Pregabalin + Dexamethasone
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Paracetamol + Pregabalin
Number of subjects: 131

Group type: COMPARATOR
Intervention: Paracetamol + Placebo
Number of subjects: 131
Study: 19834266

Group type: EXPERIMENTAL
Intervention: Follicle phase
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Menstruation phase
Number of subjects: 12
Study: 16456410

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei shirota (LCS)
Number of subjects: 28
Study: 14976782

Group type: EXPERIMENTAL
Intervention: rapacuronium 1000 micrograms.Kg‐1 (bolus)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rapacuronium 100 micrograms.Kg‐1 (priming)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rocuronium 400 micrograms.Kg‐1 (bolus)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rocuronium 60 micrograms.Kg‐1 (priming)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mivacurium 100 micrograms.Kg‐1 (bolus)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mivacurium 10 micrograms.Kg‐1 (priming)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mivacurium (priming)
Number of subjects: 120